Private equity firm Altus Capital Partners has acquired specialised spinal implants manufacturer ChoiceSpine for an undisclosed sum.

ChoiceSpine also designs and markets instrumentation and biologics for the surgical treatment of complex spine disorders.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

ChoiceSpine and Knox Spine develop new products in collaboration with physicians. Products incorporate existing medical technology with customised patient solutions.

Altus Capital Partners co-founder and senior partner Gregory Greenberg said: “We recognise the need in the medical technology space for proven spinal products that can enhance the quality of life for spinal patients.

“ChoiceSpine, a global medical device corporation specialising in innovative solutions for both spinal fusion hardware and biologics, demonstrates a track record of proven innovation, strong sales growth, increased distribution and the necessity of their products in the marketplace.”

“We recognise the need in the medical technology space for proven spinal products that can enhance the quality of life for spinal patients.”

The company’s management will continue to invest in the expansion of the business.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The latest deal is said to be Altus’s second acquisition in the medical technology space.

In December last year, the company completed the tender offer to acquire all of the outstanding shares of common stock of global medical technology company dedicated to cardiorespiratory health solutions, MGC Diagnostics.

ChoiceSpine founder Marty Altshuler said: “We look forward to working with Altus in further developing our offerings as well as expanding into new product verticals to continue to grow the company and provide patient solutions for the treatment of spinal disorders.”

ChoiceSpine manufactures minimally invasive, cervical, thoracolumbar, interbody, lateral, and biologics kits and implants.